Cytoagents, Inc.

United States of America

 
Total IP 13
Total IP Rank # 116,945
IP Activity Score 2/5.0    16
IP Activity Rank # 52,942
Dominant Nice Class Scientific, technological and in...

Patents

Trademarks

6 1
2 0
4 0
0
 
Last Patent 2024 - Car t-cell adjuvant therapies
First Patent 2007 - Ep2 and ep4 agonists as agents f...
Last Trademark 2021 - CYTOAGENTS
First Trademark 2021 - CYTOAGENTS

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Car t-cell adjuvant therapies. Compositions, methods, and kits that can be used to treat cancer ...
2023 Invention Chimeric antigen receptor (car) t-cell adjuvant therapies. Methods, compositions, and kits that c...
Invention Chimeric antigen receptor (car) t-cell adjuvant therapies. Methods, compositions, and kits that ...
Invention Bispecific antibody therapies. Compositions, methods, and kits that can be used to treat cancer, ...
Invention Bispecific antibody therapies. Compositions, methods, and kits that can be used to treat cancer,...
2021 Invention Car t-cell adjuvant therapies. Compositions, methods, and kits that can be used to treat cancer a...
G/S Scientific research and development services in the field of biotechnology
Invention Compositions and methods for treating coronavirus infections. Compositions and methods that can b...
2011 Invention Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection. The present inve...